Australia's most trusted
source of pharma news
Posted 31 January 2025 AM
The pharma industry is feeling positive about its growth prospects in 2025 however the level of optimism is lower than six months ago, according to analysts at GlobalData.
There's an air of caution associated with changes in government, geopolitical tensions including ongoing conflicts and the impact of the US Biosecure Act which aims to break down relationships between US federal agencies and American companies that have contracts with 'companies of concern' from countries such as China, North Korea, Russia and Iran.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.